MedPath

3D Reconstruction in Video-assisted Thoracoscopic Surgery (VATS) Segmentectomy

Not Applicable
Completed
Conditions
Segmentectomy
Interventions
Other: 3D reconstruction
Registration Number
NCT04004494
Lead Sponsor
Ruijin Hospital
Brief Summary

Anatomical variations of pulmonary vessel may cause serious problems during pulmonary segmentectomy. Three-dimensional (3D)computed tomography (CT) presents 3D images of pulmonary vessels and the tracheobronchial tree and may help operative planning. Retrospective studies have identified the importance of 3-dimensional CT in the field of pulmonary segmentectomy. And the aim of this study is to compare the usefulness of 3-dimensional CT with standard chest CT in preoperative planning of video-assisted segmentectomy.

Detailed Description

Lung cancer has been the most serious malignancy around the world which has the highest morbidity and mortality amount all the malignant tumors. Due to the wide spread of lung cancer screening, more and more early stage lung cancer patients have been diagnosed. Video-assisted segmentectomy is a standard surgical procedure in treating early stage peripheral non-small cell lung cancer (NSCLC). However, anatomical variations of pulmonary vessel may cause serious problems, for example unexpected bleed during surgery. Three-dimensional computed tomography (CT), which is reconstructed based on the standard chest CT image, presents 3D images of pulmonary vessels and the tracheobronchial tree and therefore helps operative planning. There are several retrospective studies addressed the importance of 3-dimensional CT in the field of pulmonary segmentectomy. And the aim of this multicenter randomized controlled trial is to compare the usefulness of 3-dimensional CT and standard chest CT in preoperative planning of video-assisted segmentectomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
191
Inclusion Criteria
  1. Age older than 18 years;

  2. Pulmonary nodules or ground glass opacification (GGO) found in chest CT examination, and conform with indications for segmentectomy:

    Peripheral nodule 0.8-2 cm with at least one of the following:

    i. Histology of adenocarcinoma in situ; ii. Nodule has ≥50% ground-glass appearance on CT; iii. Radiologic surveillance confirms a long doubling time (≥400 days). Segmentectomy should achieve parenchymal resection margins ≥2 cm or ≥ the size of the nodule.

  3. Adequate cardiac function, respiratory function, liver function and renal function for anesthesia and VATS segmentectomy.

  4. American Society of Anesthesiologists (ASA) score: Grade I-III.

  5. Patients who can coordinate the treatment and research and sign the informed consent.

Exclusion Criteria
  1. Patients with a significant medical condition which is thought unlikely to tolerate the surgery. For example, cardiac disease, significant liver and renal function disorder.
  2. Patients with psychiatric disease who are expected lack of compliance with the protocol.
  3. Patients have history of chest trauma or surgery on ipsilateral chest which may cause pleural adhesion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
3D Reconstruction3D reconstructionChest contrast-enhanced computed tomography will be performed preoperatively, and 3-dimensional reconstruction will be formed based on the data of chest CT. Video-assisted segmentectomy will be performed guided by the image of 3-dimensional CT. IPS-lung software (Shenzhen Yorktal Digital Medical Imaging Technology Company, Shenzhen, China) will be used preoperatively to construct a 3D-image to ascertain the position and structure of targeted segmental blood vessels and bronchi.
Primary Outcome Measures
NameTimeMethod
operative timeDuring surgery

the time of operation

Secondary Outcome Measures
NameTimeMethod
Duration of chest tube placementUp to 4 weeks

Duration of chest tube placement

Postoperative hospital stayUp to 24 weeks

length of stay in hospitalization

blood lossDuring surgery

Amount of intraoperative blood loss

Incidence of postoperative complicationsPostoperative in-hospital stay up to 30 days

mainly include: pneumonia, arrhythmia, incision infection, vocal cord paralysis, trachea cannula

Preoperative lung functionBaseline

forced expiratory volume at one second(FEV1) in litre, maximal voluntary ventilation (MVV) in litre

conversion rateDuring surgery

the rate of conversion to open surgery in the operation

30-day mortalityPostoperative in-hospital stay up to 30 days

30-day mortality after surgery

Disease-free survival (DFS)up to 60 months

Up to the date of disease recurrence since the date of randomization

Postoperative lung functionat the 3rd month after surgery

forced expiratory volume at one second(FEV1) in litre, maximal voluntary ventilation (MVV) in litre

operative accident eventDuring surgery

the accident event happened in operative. For example, a segmentectomy is converted to a lobectomy

dissection of lymph nodes2 weeks after surgery

including overall lymph node count, number of stations dissected and number of lymph nodes in each lymph node station

Overall survival (OS)up to 60 months

Up to the date of death of any causes since the date of randomization

Incidence of change of surgical planDuring surgery

Surgical plan is made based of the image of standard chest computed tomography or three-dimensional computed tomography, the targeted segmental bronchus and pulmonary vessels are decided preoperatively. Change of surgical plan is recorded when the actually resected bronchus and vessels are different to those in the preoperative surgical plan

Trial Locations

Locations (3)

Guangdong General Hospital

🇨🇳

Guangdong, Guangdong, China

Union Hospital of Fujian medical university

🇨🇳

Fujian, Fujian, China

Ruijin Hospital, Shanghai JiaoTong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath